
NHRC Issues Notices Over Failed Quality Test of Epilepsy Drug ‘Sodium Valproate’
NHRC Issues Notices Over Failed Quality Test of Epilepsy Drug ‘Sodium Valproate’
The National Human Rights Commission (NHRC) in India took suo motu cognizance of a media report indicating that ‘Sodium Valproate,’ a medication prescribed for epilepsy treatment in Delhi government-run hospitals and Mohalla Clinics, did not meet the required standards in a quality test conducted by the Regional Drug Testing Laboratory (RDTL) in Chandigarh. This issue was raised in a press release by the NHRC.
As per the media report cited, the Directorate of Vigilance released findings indicating that, out of a total of 43 medicine samples examined by government laboratories, four samples failed the quality test. Additionally, the report for 11 samples is yet to be disclosed. The release highlighted that another medicine recommended for epilepsy treatment also showed inadequacy.
Expressing concern over potential human rights violations if the reported findings are accurate, the NHRC issued notices to key authorities, including the Delhi Chief Secretary, the Drugs Controller General of India, and the Police Commissioner, seeking a comprehensive report within four weeks.
The press release also mentioned that as of December 28, five medicines, including those prescribed for conditions such as hypertension, excess acid influx, joint pain, and lung swelling, have been banned due to similar concerns raised by the media report.
The NHRC’s proactive step aims to address potential violations and ensure the safety and efficacy of medications administered to patients, specifically targeting the quality of drugs distributed for critical health conditions like epilepsy.
Latest Posts
- WhatsApp Puts Multiple Accounts ‘Under Review’, Blocks Access For 24 Hours
August 4, 2026 | Breaking News, Social Media - Centre Hikes Windfall Gains Tax On Export Of Petrol, Diesel Amid Iran War
August 4, 2026 | Breaking News, India - NEET Paper Leak Dominates Punjab Assembly Session, AAP Attacks BJP
August 4, 2026 | Breaking News, India, Politics - LIC Stake Sale Begins Tuesday; India Government Launches LIC OFS
August 4, 2026 | Breaking News, Business, India - Fresenius Medical Care beats quarterly profit estimates, sticks to 2026 outlook
August 3, 2026 | Breaking News, Business, Markets - Ukraine Removes US Ambassador Olha Stefanishyna From Post
August 3, 2026 | Breaking News, Politics, World - FSSAI Prohibits Sale of Dabur India Products Carrying Misleading ‘100%’ Claims
August 3, 2026 | Breaking News, Business, India - Citi hires Bank of America’s Rohan Sen to lead technology services banking
August 3, 2026 | Breaking News, World - UBS Fined $125 Million by US Regulators for Anti-Money Laundering Violations
August 3, 2026 | Breaking News, Business, Markets - SAS airline cabin crew in Norway plan to go on strike from August 8
August 3, 2026 | Breaking News, Business, Markets